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Abstract
Introduction
Preclinical CT-guided radiotherapy platforms are increasingly used but the CT images are
characterized by poor soft tissue contrast. The aim of this study was to develop a robust and
accurate method of MRI-guided radiotherapy (MR-IGRT) delivery to abdominal targets in
the mouse.
Methods
A multimodality cradle was developed for providing subject immobilisation and its perfor-
mance was evaluated. Whilst CT was still used for dose calculations, target identification
was based on MRI. Each step of the radiotherapy planning procedure was validated initially
in vitro using BANG gel dosimeters. Subsequently, MR-IGRT of normal adrenal glands with
a size-matched collimated beam was performed. Additionally, the SK-N-SH neuroblastoma
xenograft model and the transgenic KPC model of pancreatic ductal adenocarcinoma were
used to demonstrate the applicability of our methods for the accurate delivery of radiation to
CT-invisible abdominal tumours.
Results
The BANG gel phantoms demonstrated a targeting efficiency error of 0.56 ± 0.18 mm. The
in vivo stability tests of body motion during MR-IGRT and the associated cradle transfer
showed that the residual body movements are within this MR-IGRT targeting error. Accurate
MR-IGRT of the normal adrenal glands with a size-matched collimated beam was confirmed
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by γH2AX staining. Regression in tumour volume was observed almost immediately post
MR-IGRT in the neuroblastoma model, further demonstrating accuracy of x-ray delivery.
Finally, MR-IGRT in the KPC model facilitated precise contouring and comparison of differ-
ent treatment plans and radiotherapy dose distributions not only to the intra-abdominal
tumour but also to the organs at risk.
Conclusion
This is, to our knowledge, the first study to demonstrate preclinical MR-IGRT in intra-abdom-
inal organs. The proposed MR-IGRT method presents a state-of-the-art solution to enabling
robust, accurate and efficient targeting of extracranial organs in the mouse and can operate
with a sufficiently high throughput to allow fractionated treatments to be given.
Introduction
It is prerequisite, when translating preclinical findings to the clinic, that the animal models
and techniques should mimic aspects of the human disease and treatment faithfully [1]. For
simple superficial tumours, including xenografts, radiotherapy (RT) dose prescription and
delivery is typically based upon wide-field irradiation with visually-guided lead shielding of tis-
sues to remain unirradiated [2]. Where more complicated, but increasingly clinically relevant,
orthotopic and genetically engineered mouse models are used this is not an option as the
tumours are often internal, and visual guidance is not possible [3–5]. This limitation is being
addressed by preclinical image-guided radiation treatment (IGRT) platforms, recently devel-
oped to mimic the clinical paradigm of irradiation planning and delivery [6].
An overview of the small animal IGRT research platforms was presented by Verhaegen et al
in which it is stated that the majority of radiotherapy platforms are paired with x-ray computed
tomography (CT)[6]. This replicates the clinical situation and enables dose estimation via CT
imaging of the electron density of each tissue type. Unfortunately, in the case of low energy
small animal irradiators, CT provides an inherently poor contrast between soft tissues [7].
This poses a significant problem for abdominal organs, orthotopic tumours and even some
xenografts since meaningful delivery of radiotherapy is difficult without correct localisation
and delineation of the target. Furthermore, the estimation of dose distribution to the organs at
risk (OARs), especially for intra-abdominal tumours is practically impossible.
To attempt to overcome the disadvantages of CT, another strategy, termed reverse-contrast
imaging, has been proposed for enabling RT of pancreatic cancer [8]. Here, CT was used for
IGRT but with the intraperitoneal space filled with CT contrast agent. Although physical sepa-
ration of the abdominal structures was achieved, the accuracy of dose estimation remained
limited [6]. Other imaging modalities such as Positron Emission Tomography (PET) and Bio-
luminescence imaging (BLI) also have been proposed to guide targeting and delivery of radio-
therapy [2, 9–11] but both techniques have their inherent limitations. BLI is restricted by its
light penetration depth, lack of true tomography imaging and requires the use of reporter
genes whilst PET applications are also limited by partial volume effects and in some cases,
inadequate contrast specificity. In contrast to CT, Magnetic Resonance Imaging (MRI) pro-
vides exquisite soft tissue contrast that can often be optimised for the organ of interest. How-
ever, MRI has to date been used merely as a descriptor of target location [2, 12] in studies
involving organs other than the brain. MRI-guided radiotherapy (RT) has only focussed on
Efficient and robust MR-IGRT method for abdominal organs and tumours mouse
PLOS ONE | https://doi.org/10.1371/journal.pone.0176693 April 28, 2017 2 / 21
institutes-units-centres/list-of-institutes-units-
centres/; award MC_PC_12004) and the Kidani
Memorial Trust. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
brain, an organ that is easy to immobilise with internal, fixed landmarks [2, 9, 11, 12]. As such,
the skull’s bright intensity on CT but dark intensity on MRI was used to drive a rigid body reg-
istration. This approach is aided by the fact that the skull encapsulates that target tissue of
interest. Moreover, the brain will remain relatively stationary within the skull even where
gross body deformations occur in-between MR and CT acquisitions. In contrast, within the
body such a rigid, encapsulating boundary to drive the registration does not exist and other
solutions must be sought. More recently, CT was omitted in a MRI-only RT workflow but, by
doing so, its usefulness was restricted to the rat brain as only limited tissue classes were avail-
able for accurate dose planning. Furthermore a common coordinate system between the MR
and RT systems was missing [11].In short no general solution has been proposed to accurately
target defined anatomical structures that are not resolved upon CT imaging.
The aim of this study was to develop a robust and accurate method of MRI-guided radiother-
apy (MR-IGRT) delivery to abdominal targets in the mouse. To achieve this, subject immobili-
sation throughout the whole procedure is crucial as accurate registration of MRI-to-CT images
will depend on the magnitude of intra- and/or inter-scan displacements [10, 13]. A multimodal-
ity cradle was therefore developed, enabling transfer of the mouse without the introduction of
large scale intra-subject motion between any of our imaging systems (MRI at 4.7T, 7.0T and
9.4T, PET, CT and Single Photon Emission Computed Tomography) and the IGRT platform.
Whilst central to the deployment of the proposed MR-IGRT technique, the animal support cra-
dle, which incorporated anaesthetic gas delivery, rectal temperature maintenance and respira-
tory monitoring, solved only part of the requirement. In addition, newly-developed rapid and
respiratory motion desensitised T2-weighted MRI imaging techniques were used together with
a deformable registration technique, based on the one described by Heinrich et al., [14] to guide
the MR-CT registration and to localise the tumours or organs of interest.
Each step of the radiotherapy planning process was validated, both in vitro using BANG gel
dosimeters and in vivo using different animal models. The in vitro tests were based on clinical
routine where the systematic accuracy of RT delivery is tested by using radiosensitive polymer
gels to validate 3-dimensional dosimetry for brachytherapy treatment planning, conformal
and intensity modulated radiotherapy techniques and stereotactic radiosurgery [13–15]. These
gels polymerise following exposure to ionising radiation, and the resulting absorbed radiation
dose fixated in the polymer gel can be read out by several imaging techniques, including MRI.
As such they can be used to measure the 3D dose distributions of geometrically complex radio-
therapy dose schemes. An overview of their history and working mechanism is presented else-
where [15]. Such gels are commercially available and can be delivered ready-for-use, thus
avoiding the intricate manufacturing process and giving highest MR sensitivity upon irradia-
tion [16, 17]. This method provides a tool for simulating the entire treatment procedure and
offers high-resolution 3D dose distribution measurements.
Next, in vivo models with increasing complexity and clinical relevance were used to validate
the MR-IGRT workflow in vivo. MR-IGRT of single adrenal glands and subsequent histologi-
cal staining based on γH2AX imaging was performed to confirm selective targeting in vivo.
The SK-N-SH neuroblastoma xenograft model was used to demonstrate the applicability of
our methods for evaluation of response-to-treatment. Finally, the applicability of MRI-guided
RT planning for use in abdominal tumours was demonstrated using the KPC model of pancre-
atic ductal adenocarcinoma (PDAC)[15].
Materials and methods
The overall workflow and design of the study is presented as a flowchart in the supplementary
data S1 Fig.
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Animals
Ethics statement. All procedures were conducted in accordance with the Animals Scien-
tific Procedures Act of 1986 (UK) (Project License Numbers 30/3059, 30/2922 and 30/3266
issued by the Home Office). The protocol was approved by the Committee on the Ethics of
Animal Experiments of the University of Oxford.
Animals and husbandry. CBA/CaCrl mice (Mus Musculus) (Charles River, UK) were
used for assessments of body motion and for the in vivo testing of MR-IGRT to the adrenal
glands. BalbC nude mice (Charles River, UK) were used for examination of the response to
MR-IGRT in a xenograft model of neuroblastoma. KPC (K-rasLSL.G12D/+; p53R172H/+; PdxCretg/
+) mice (Beatson Institute, Glasgow, UK) were bred in the biomedical services unit at the Uni-
versity of Oxford and were used to examine the potential of MR-IGRT in a spontaneous
model of pancreatic cancer [16].
All mice were housed in individual ventilated cages in a separate room with 12-h dark and
light cycle maintained at 22˚C in 50% humidity. They were provided with certified rodent
diet, filtered water ad libitum, autoclaved bedding material and cage enrichment. No mice had
to be euthanized on welfare grounds.
Anaesthesia for imaging and RT. Anaesthesia was induced and maintained using isoflur-
ane (1–4%) in room air supplemented with oxygen (80%/20% v/v). Animals were placed in
head-first supine position for imaging. Animals were either recovered afterwards with no ill
effect, or culled humanely in the case of in vivo targeting validation. Throughout imaging
experiments, mice were maintained at 37˚C core temperature, respiration rate was monitored
and maintained in the range of 40–60 breaths/minute.
Animal support apparatus
Multi-modal cradle design. A custom-made MR and CT compatible animal support cra-
dle was assembled as shown in Fig 1. Two 300 mm long acrylic tubes (i.d. 25 mm, o.d. 30 mm;
The Plastic Shop, UK) were cut along the axis to give two halves that formed a cylinder when
pushed together. The mouthpiece assembly consisted of a base block, a vertically and horizon-
tally adjustable mouth bar and an anaesthetic gas delivery tube. The bottom half-tube was
screwed to a trapezoidal base which mated with a support block used as part of the MRI sup-
port cradle. The top half-tube was supported on a ring and a locator screw mounted on the
bottom half-tube. For cone beam CT (CBCT) imaging and subsequent radiotherapy using the
IGRT system, the bottom half-tube was mated with a support block mounted on top of the
robotic stages such that the cradle was kept within the 190 mm radius to prevent collisions
resulting from rotation of the cradle while obtaining the CBCT image. Individual components
were drawn using CAD software (Solidworks, Dassault Systèmes) and printed using a 3D
printer (HP Designjet 3D).
Temperature maintenance. Core body temperature was monitored using a rectal OTP-
M high accuracy temperature sensor (part number OTP-M-X-62F2.5–1.5(PTFE/PVC)-XN-
7GT-M1-PV0014a, Opsens Industrial) connected via a 10 m fibre-optic extension to an Accu-
Sens 4 channel Signal Conditioner (part number ACS-P4-N-62SC). A thin layer of epoxy adhe-
sive was applied over the last few millimetres of the probe to smooth over any sharp edges that
could injure the animal. An analogue output voltage available from the signal conditioner was
used to control the heating circuit. Temperature was maintained at 37˚C core temperature
using a custom-made homeothermic electrical driver unit based around a programmable con-
troller unit (Arduino) which delivered current into an MR-compatible twisted pair wire resistor
[17]. The heating blanket was positioned beneath the animal and below the plane of rotation of
the CT imaging gantry to avoid overt metal streak artefacts in the reconstructed CT images.
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Respiration monitoring and generation of respiratory control signals for gated imag-
ing. Respiration was monitored using a custom-made fibre optic reflection displacement sen-
sor which uses closely spaced transmission and reception polymer optical fibres. These were
placed through apertures spaced along the length of the top half-tube such that they faced a
moving part of the body, due to respiration and in the expected vicinity of the target tissue to
be irradiated.
The analogue optical displacement signal indicating respiratory motion was passed through
a commercial gating control unit (DTU 200, Biopac Inc. CA). This unit forms a threshold-
defined binary logic signal that instructs the MR scanner, in real time, whether to acquire
data or not. Since some change in the signal level is required in order for the threshold to be
reached (along with hysteresis to avoid repetitive noise triggering), some respiratory-derived
data corruption is to be expected unless additional measures are taken. For the trailing exhala-
tion edge, the respiration motion artefact was minimized by passing the thresholded (logic)
signal through a monostable and gating circuit that extended, by a user variable delay time, the
Fig 1. Photograph of the animal support cradle. (A) Animal support cradle mounted in the MRI cradle assembly showing (a) MRI support cradle, (b)
mounting block for the optical fibres for respiration monitoring, (c) optical fibres for respiration monitoring, (d) trapezoidal base of the animal support cradle
which mated with a support block on the MRI support cradle, (e) RF coil. (B) Close-up of animal support cradle showing (f) mouthpiece assembly consisting
of a base block, a vertical and horizontal adjustable mouth bar and an anaesthetic gas delivery tube, (g) electrical heating blanket, (h) optical fibre for
temperature monitoring, (i) top of the animal support cradle with access points for the optical fibres for respiration monitoring, (j) quick-fit connector for
electrical heating pad, (k) anaesthetic gas delivery tube with quick-fit connector and (l) power cable for the electrical heat delivery.
https://doi.org/10.1371/journal.pone.0176693.g001
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duration of the logic signal used to drive the scanner without data acquisition. In order to
avoid respiration motion artefact from the leading, inhalation, edge of the breath, the MR
scanner was programmed to reacquire a user-variable number of data blocks immediately
after the same breath.
Transfer between MRI and IGRT system. The heater power cable, the optical fibres for
respiration and temperature monitoring, and the tubing for anaesthetic gas delivery had
‘quick-fit’ connectors located at the animal cradle. The animal in its cradle could be thus
quickly and easily detached from the physiological support apparatus located at the MRI
scanner, transported to the IGRT system and re-connected to the IGRT physiological support
system. Both the MRI scanner and IGRT system had their own independent, duplicated physi-
ological monitoring and maintenance systems which were based around a commercial physio-
logical monitoring system (MP150, Biopac Inc., CA).
Mechanical accuracy testing using BANG polymer gel dosimeters
The in vitro target testing was performed to demonstrate that there were no systematic errors
consequent to (a) the combination of images acquired using fundamentally different localisa-
tion techniques and (b) the imaging systems, produced by 2 different manufacturers, with no
previous reference to each other.
Preparation of Rotationally-asymmetric BANG gels. Under anoxic conditions in a hyp-
oxia chamber (INVIVO2 300, Ruskinn, Bridgend, UK), BANG gels (MGS Research Inc,
Madison, USA) were melted at 37˚C and placed in glass vials that were angled such that, when
the gels set, the meniscus was not horizontal [18]. The BANG gels were allowed to equilibrate
to room temperature before imaging and radiotherapy was initiated. The BANG gels were
stored in the dark at 4˚C.
RT planning CBCT image. CT was performed using the standard cone beam CT (CBCT)
imaging component of the Small Animal Radiation Research Platform (SARRP, Xstrahl, Sur-
rey, UK). CBCT images were acquired using 70 kVp (BANG gels) X-rays (fine focus, 0.15 mm
Cu filter) with 720 projections taken as the sample is rotated through 360˚ in a scan time of
127 s. Additional filtration results from the presence of a transmission monitor (in total: 0.105
mm Cu and 1 mm of FR4 a fibreglass/epoxy mix). This CT acquisition will be referred to as
‘RT planning CBCT image’. CBCT images were reconstructed using a modified Feldkamp-
Davis-Kress reconstruction algorithm into 0.16 mm isotropic voxels. The dose per CBCT scan
was typically 56.9 ± 2.8 mGy 70 kVp CT imaging, and was determined using EBT3 gafchromic
film (Vertec Scientific Ltd) sandwiched in the middle of a 25.4 mm diameter water-equivalent
(WT1; Barts and the London NHS Trust) cylinder as described before [19].
RT targeting. Therapeutic exposures were performed using 220 kVp X-rays (broad focus,
0.15 mm Cu filter and a half value layer of 0.93 mm Cu) delivered using the SARRP irradiator
in conjunction with collimators to produce a range of field sizes. Additional filtration results
from the presence of a transmission monitor (in total: 0.105 mm Cu and 1 mm of FR4 a fibre-
glass/epoxy mix). For each collimator, dosimetry was performed using an EBT3 film as
described before, with the film calibrated following the recommendations of the report of the
American Association of Physicists in Medicine Task Group 61 [20, 21]. Treatment planning
and subsequent beam delivery was performed using Muriplan (Xstrahl Ltd, Camberley, Sur-
rey, UK), with targeting and subsequent segmentation performed using the CBCT image [22].
Delivery of intersecting RT beams to form a target for MR-IGRT. The rotationally-
asymmetric gels (n = 5) were placed vertically in the IGRT system. Following the low dose RT
planning CBCT image, the gels were irradiated with a pair of orthogonal 2 mm or 4 mm in
diameter circular beams each with approximately 2 Gy. Approximately 4 Gy was thus
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delivered to the intersection of the beams which had a volume of 4.2 or 33.5 mm3. The inter-
section was positioned in a way such as to avoid mirror image symmetry.
Definition of a RT planning MR and CT image. MRI was performed at 4.7 T (VNMRS,
Varian Inc., Palo Alto, CA) using a 40 mm ID quadrature birdcage coil (Rapid Biomedical
GmbH, Rimpar, Germany). The BANG gels were scanned with a 3D CE-FAST sequence [23]
with TR 3.672 ms, TE 1.836 ms, bandwidth 100 kHz, FOV 70×35×35 mm3, matrix 256×128×128
and a 40˚ degree, 64 μs hard pulse. This CE-FAST scan was used as it showed adequate contrast
between the raw BANG gel, the path of each 2 Gy beam and the intersection of the 2 beams. A sec-
ond low dose RT planning CBCT scan was performed for targeting the calculated point of the
intersecting beams.
Registration of the RT planning MR and CT images. As the CBCT image showed the
glass of the vial as well as the BANG gel, the outer surface of the gel was used to guide the regis-
tration. From the CBCT image volume, only the gel, and not the glass vial, was segmented
using the ITK-Snap (ITK-SNAP) region growing tool [24]. The MR image only showed the gel
so the outer edge of the image was sufficient to drive the registration. The surfaces of these two
gel masks were converted into a set of points which were aligned using a finite iterative closest
point algorithm in MATLAB (The MathWorks, Inc., Natick, Massachusetts, United States).
The transformation between the two sets of points was used to register the MR image volume
to the CBCT image volume. The BANG gel samples were rotationally asymmetric volumes so
that fiducial markers were not necessary for the MR-to-CBCT co-registration. The CT image
defined the position of the object within the RT system and the combined CBCT-MR image
then defined position of the intersecting beam target within the RT system.
RT planning on the intersecting beam target. The operator identified the centre of the
intersecting beams in 3 dimensions using the Muriplan software. This isocentre was used to
define the centre of rotation for a conical arc treatment, delivered at a 45 degree oblique angle,
using a 5 mm round collimator and a 360˚ rotation of the beam with respect to the sample. A
dose of 4 Gy was delivered to the rotational isocentre.
Assessment of RT planning accuracy by MRI. The same CE-FAST MRI scan was
acquired after both the delivery of the target formation and the target treatment scans. The
images were segmented using ITK-Snap [24] and any positional offsets between the centres of
the intersecting beams and the treatment spheres were determined.
In vivo stability of body position
Whilst BANG gel tests offered a means for establishing the degree of mechanical accuracy of
RT treatment delivery, they did not present the problems associated with delivery of RT to a
living animal. Assessments were made of the stability of animal and organ positions within the
body as a function of time (intrinsic motion) and that of animals being moved repeatedly
between MRI and IGRT treatment systems (extrinsic motion). The intrinsic motions, includ-
ing respiration, peristalsis, bladder filling, and body sag, are unavoidable and present the fun-
damental limit to the accuracy with which RT can be delivered. Extrinsic body motions may
be introduced by a combination of imperfect cradle design and incompetent transfer of the
animal in its cradle from the MR scanner to the RT system.
MRI methods. Scans were performed at 7.0 T with a respiratory-gated 3D balanced
SSFP (bSSFP) sequence [25] with TR 3.268 ms, TE 1.134 ms, FOV 64×32×32 mm3, matrix
256×128×128 and a 15˚ degree flip with a 16 μs hard pulse [26, 27]. Scans were performed with
and without RF phase alternation in order to generate a maximum-intensity projection image
with reduced banding artefacts from local magnetic field inhomogeneities. Scan time was res-
piration-rate dependent but lasted typically about 3 minutes.
Efficient and robust MR-IGRT method for abdominal organs and tumours mouse
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Image registration. All rigid body registrations between sequentially acquired MR images
were performed using the ‘imregister’ function built into MATLAB.
Evaluation of intrinsic motions. The bSSFP scan was repeated every 5 minutes for
approximately 30 minutes for 5 CBA mice and to monitor stability of body position in the
absence of external influences. Motion was assessed by taking the difference image of sequen-
tially acquired images in ImageJ (author Wayne Rasband, Research Services Branch, National
Institute of Mental Health, Bethesda, Maryland, USA) [28].
Evaluation of extrinsic motions. The bSSFP scan was performed prior to the animal in
its cradle, being moved to the IGRT system, where a dummy CBCT-IGRT procedure without
x-ray delivery, was performed. The animal was then returned to the MRI system and this cycle
was repeated 4 further times. Using the cradle hardware described, it was not possible to return
the animal and cradle to identical positions within the magnet with each consecutive loading,
and rigid body registrations were performed to assess this. Deformable registration methods
could not be used here as they would have concealed the residual motions. Motion was
assessed by taking the difference image of sequentially acquired images in ImageJ [28].
In vivo MR-IGRT of the adrenal glands and histological validation by
γH2AX staining
MRI methods. The bSSFP scan as described in the section ‘In vivo stability of body posi-
tion’ was used.
RT planning CBCT image. An RT planning CBCT image was acquired as described in
the ‘Mechanical accuracy testing using BANG polymer gel dosimeters’ section but 50 kVp and
not 70 kVp X-rays were used which resulted in a typical dose per CBCT scan of 22.7 ± 1.1
mGy.
Image registration. First a rigid body registrations between MR to CBCT images was per-
formed using the ‘imregister’ function built into MATLAB. A further non-rigid registration
step was required to compensate for the non-linear spatial distortions inherent in MR imaging,
and was performed using the ‘MIND’ algorithm [14]. The bSSFP images had sufficient resolu-
tion and contrast to identify the adrenal glands and to drive the MR to CT image registration
reliably.
MR-IGRT methods. In 4 CBA mice, positioned supine in the cradle, the bSSFP scan was
used to identify the adrenal glands. This MR image was co-registered with the RT planning CT
as described above and the combined CT-MR image was used to guide the RT treatment deliv-
ery. In 2 mice the left adrenal gland was targeted while the right adrenal was targeted in the
remaining 2 mice. MRI-guided radiotherapy (10 Gy dose) was achieved using a 2 or 3 mm cir-
cular field (the collimator size was matched to the imaged size of the adrenal gland), with the
beam delivered as a single beam passing anterior-to-posterior through the body.
Tissue preparation for γH2AX staining and confocal microscopy. Mice were not
allowed to recover from anaesthesia and were culled 30 minutes post RT. Both adrenal glands
were removed from each body, and histology, microscopy and analysis was performed by an
operator blinded to the treatment schedule. The adrenal glands were collected, fixed in 10%
neutral buffered formalin for 24 h, transferred to 70% ethanol for 24 h, and embedded in par-
affin. The entire adrenals were cut into 5 micrometre sections and the sections were allowed to
dry overnight. Following antigen retrieval (20 min, 100 ˚C, 10 mM sodium citrate buffer,
pH6), the sections were permeabilized (1% triton X-100 in phosphate-buffered saline (PBS),
10 min, room temperature), blocked (Mouse-on-Mouse block (Vector Laboratories, UK), 5
drops/2.5 ml, overnight, 4 ˚C and 2% bovine serum albumin in PBS, 2 h, room temperature),
and incubated with monoclonal anti-γH2AX antibodies raised in mouse (overnight, 4 ˚C,
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1:500; p-yH2AXSer139 in the formulation of clone JBW301, Millipore, UK). An Alexa-594
labelled horse anti-mouse monoclonal antibody was used as secondary antibody (1h, room
temperature, 1:500; DI-2488, Lot ZB0318, Vector Laboratories, UK), and DAPI (1:1000, BD
Pharmingen, UK) was used for nuclear staining. Sections were mounted with Vectashield
hardset antifade mounting medium (Vector Laboratories, UK), and images acquired using
confocal microscopy (Leica TCS). Haematoxylin and Eosin (H&E) staining was performed as
described before [29] and slides were scanned using Aperio Slide Scanner (Leica Biosystems,
UK). All chemicals, unless stated otherwise, were purchased from Sigma-Aldrich UK.
In vivo MR-IGRT of neuroblastoma xenografts
MRI methods. MRI imaging, using the bSSFP scan, was performed as described in the
section ‘In vivo stability of body position’.
RT planning CBCT image and Image registration. CBCT imaging and subsequent
image registration was performed as described in the section ‘In vivo MR-IGRT of the adrenal
glands and histological validation by γH2AX staining’.
MR-IGRT methods. NOD scid gamma mice (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ, Charles
River, UK) were used as a host to generate human neuroblastoma tumours after subcutane-
ous injection of 5x106 SK-N-SH cells (ATCC-HTB-11; LGC Standards, Middlesex, UK) in
Matrigel (1:1 culture medium/Matrigel; BD Biosciences, Oxford, UK) in the right flank [30].
The tumour was excised 5 weeks post inoculation and following homogenisation, a crude
suspension of SK-N-SH human neuroblastoma xenograft cells was injected into the right
flank of BALB/c nu/nu mice (Charles River, UK; n = 8). Tumours entered the study when
they reached 8 mm GMD (gross maximum diameter), approximately 7 weeks post inocula-
tion. To monitor tumour response to radiotherapy, 5 mice underwent MR-IGRT and 3 were
used as a control.
The bSSFP MRI scan was used to monitor tumour growth for entry into the study, for
enabling MR-IGRT, and for monitoring the response to treatment. The MR image was co-reg-
istered with the RT planning CBCT as described above and the combined CBCT-MR image
was used to guide the RT treatment delivery. A single 5 Gy beam was applied using the most
appropriate collimator depending on the size and shape of the tumour to ensure complete cov-
erage. In some mice, due to the limited number of collimator sizes available, more than one
field was used in order to cover the whole tumour whilst ensuring minimal exposure of sur-
rounding normal tissues. Moreover, minimal overlap of the two RT fields could be applied as a
result of the sharp beam edges of the SARRP IGRT system [6, 12]. In order to maximise effi-
ciency and throughput two cradles were used: while one mouse was being irradiated, the next
mouse was undergoing MRI prior to RT. Mice were culled when tumours reached 800 mm3 as
measured by region-of-interest analysis of the MR image, performed with ImageJ.
In vivo MR-IGRT of spontaneous pancreatic tumours in KPC mice
MRI methods. MRI imaging, using the bSSFP scan, was performed as described in the
section ‘In vivo stability of body position’. Additionally, a constant TR respiratory-gated 2D
multi echo CPMG sequence using SPLICER [31] with TR 4.38 s, 8 echoes with first TE and
echo spacing 6.856 ms, FOV 64×32 mm2, matrix 192×96, 72 contiguous 0.33 mm thick slices,
was used to aid tumour identification in KPC mice. Scan time was respiration-rate dependent
but lasted typically about 10 minutes.
RT planning CBCT image. CBCT imaging was performed as described in the section ‘In
vivo MR-IGRT of the adrenal glands and histological validation by γH2AX staining’
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Image registration. Image registration was performed as described in the section ‘In vivo
MR-IGRT of the adrenal glands and histological validation by γH2AX staining’. Of the two
MR imaging sequences used, only the bSSFP was found to have sufficient resolution for reli-
able MR to CT registration. However, the transformation between bSSFP and CPMG is fixed
(since they are both acquired on the same scanner during the same imaging session), and so
the transformation found between bSSFP and CT was applied to the CPMG images. The regis-
tered MR images were interpolated to the same resolution as the CT images and stored such
that the RT planning software imported them as if they were the CT images.
MR-IGRT methods. The KPC model was used because the PDAC tumour is hard to
localise without imaging and because it lies in the immediate vicinity of a number of highly
radiosensitive organs including stomach, spleen and intestine. KPC mice develop invasive dis-
ease at age 47–355 days and survive with further development of pancreatic ductal adenocarci-
noma over the next 2 and 10 months [16]. KPC mice were screened for pancreatic tumours
every 3 weeks using bSSFP and CPMG MRI sequences. When tumours were identified at a
diameter of ca. 4–5 mm mice were entered into the study (n = 5). The CPMG scan consistently
gave the best tumour-to-normal tissue contrast and guided the localisation of the tumour cen-
tre. A dose of 2 Gy was delivered using a coronal arc beam centred on the tumour with the
beam 45˚ to the vertical and the mouse rotated through 360˚; the collimator and associated
field size was chosen to ensure full coverage of the tumour while sparing surrounding tissues.
Again, 2 cradles were used to improve time efficiency of the MRI-guided radiotherapy
procedure.
Dose-volume histograms for different RT plans. In addition, the tumour and surround-
ing OARs were contoured slice-by-slice on the co-registered CBCT-MRI images. The OAR
included stomach, bowel (small and large bowel; contoured from underneath the diaphragm
up to 3 mm below the inferior PTV margin), liver, spleen, right and left kidney. The RT dose
distributions and associated dose-volume histograms (DVH) for each organ were calculated
for four different RT plans. The plans were as follows:
1. 45˚ Arc: RT planning using a single arc administered with the gantry fixed at 45 degrees
and the mouse rotating through 360 degrees;
2. 0˚ beam: RT planning using a single static beam from 0˚;
3. 30˚+60˚ arc: RT planning using two conical arcs, one with the gantry at 30 and one at 60
degrees, both rotating through 360 degrees;
4. 2x120˚ arcs: RT planning using two arcs keeping the mouse static, and rotating the gantry
from 0 to 120 degrees one on each side (equivalent to moving the gantry from -120 to +120
degrees).
The standard dose-volume histograms were extracted using MATLAB and plotted using
the GraphPad PRISM (Version 6, GraphPad Inc., US).
Results
Mechanical accuracy testing using BANG polymer gel dosimeters
MR-IGRT targeting efficiency was evaluated by studying the 3D dose distribution in BANG
gels. The MRI-IGRT targeted 4.2 mm3 contrast volume could not be distinguished in CBCT
but was readily visualised by MRI and enabled the delivery of MR-IGRT to the centre of the
MR-visible contrast volume, as shown in Fig 2. The centre of the conical arc aligned with the
centre of the preformed sphere target with a mean offset of 0.56 ± 0.18 mm (or 2.0 ± 0.7 pixels;
n = 5).
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In vivo stability of body position
Evaluation of intrinsic motions. A representative difference image for the intrinsic
motion is presented in Fig 3A. Significant gastrointestinal motility, bladder filling and a
Fig 2. MR-IGRT of a painted feature in a BANG gel. (A)—(E): Transversal view of MR-IGRT for the 5 tested
BANG gels. A target volume was created by a pair of orthogonal 2 mm diameter (A, B, C, D) or 4 mm diameter
(E) circular beams (volume 4.2 or 33.5 mm3) and targeted following MR-IGRT using a conical arc, delivered at
a 45 degree oblique angle and using a 5 mm round collimator.
https://doi.org/10.1371/journal.pone.0176693.g002
Fig 3. In vivo stability of body position: evaluation of intrinsic motions. (A) Intrinsic motion as shown by
taking the difference of the first and last image of a 30 minute acquisition. Bladder filling (a), gastrointestinal
motility (b) and a general gravity induced body droop of up to 4 pixels (1 mm) (c, d) can be observed. The
differences in signal intensity, expressed as the percentage of the first image, are 8%, 51%, 3% and 3% for
regions a, b, c and d, respectively. (B) The corresponding anatomical image is shown.
https://doi.org/10.1371/journal.pone.0176693.g003
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general gravity induced body droop of up to 4 pixels were observed during the 30 min time
frame.
Evaluation of extrinsic motions. The difference image of MR scans performed before
and after 5 cycles of transfer of the mouse in the cradle between the MRI scanner and the
IGRT system is presented in Fig 4, illustrating the sum of intrinsic and extrinsic motions. It
must be noted that only rigid transformation was applied to correct for positional errors
between subsequent MR acquisitions. Low level distortions can be observed at the dia-
phragm and at the surface of the mouse. However, these mismatches are within 2 pixels
(equivalent to 0.56 mm) for the diaphragm and 1 pixel (i.e. 0.28 mm) for the outer surface of
the mouse and are within the MR-IGRT targeting error as described for the BANG polymer
gel dosimeters.
Fig 4. In vivo stability of body position: evaluation of extrinsic motions. (A) This represents the worst
case image for extrinsic motion as shown by taking the difference image of the MR images produced before
and after 4 cycles of transfer of the mouse in the cradle between the MR- and IGRT systems. Low level
distortions can be observed at the diaphragm (a) and at the surface (b) of the mouse. Gastrointestinal motility
(c) and bladder filling can also be observed (d). (B) The corresponding anatomical image is shown.
https://doi.org/10.1371/journal.pone.0176693.g004
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In vivo MR-IGRT of the adrenal glands and histological validation by
γH2AX staining
Although the BANG gel tests established the degree of accuracy of RT treatment delivery, they
do not represent the in vivo situation where accurate delivery of RT to the living body is crucial
and where non-rigid body registrations are part of the workflow.
The contrast sensitivity of the CBCT was not sufficient to visualise the adrenals for IGRT
planning. As a result, MR-IGRT was implemented. Respiratory-gated bSSFP MR allowed for
fast imaging (86 ± 11 s/acquisition; approximately 3 minutes total) of the abdomen, and the
adrenals could be easily localised. As a result, MR-IGRT of the adrenal gland was performed as
shown in Fig 5A–5D. The MR-IGRT procedure took approximately 50 minutes for each
mouse to complete.
MR imaging was successfully used to guide radiotherapy to one of the adrenals as con-
firmed by γH2AX staining, a marker of DNA double-strand breaks (Fig 5E). γH2AX foci anal-
ysis could distinguish the irradiated from the non-irradiated adrenal (Fig 5E, column 1 and 2
versus column 4). Moreover, the adjacent kidney to the irradiated adrenal showed background
levels of γH2AX foci (Fig 5E, column 1 and 2 versus column 3).
In vivo MR-IGRT of neuroblastoma xenografts
Fig 6 presents the MRI-guided radiotherapy plan to irradiate a SK-N-SH neuroblastoma xeno-
graft. As the MR image (Fig 6A) shows, these tumours are readily apparent but tend to grow
inwards rather than outwards and they are not discernible using the CBCT image (Fig 6B).
The respiratory-gated bSSFP scan delineated these tumours clearly and within 10 minutes of
induction of anaesthesia. Additionally, throughput was maximised by using 2 support cradles
as outlined before. As a result, MRI-guided radiotherapy of 6 animals could be completed
within 1h45min as the time to perform bSSFP fitted well within the time required to perform
CBCT-IGRT.
As proof of principle, these neuroblastoma xenografts were treated by MR-IGRT and
tumour volume was followed over time. Tumour regression was observed during the initial 5
days post radiotherapy. However, recurrence was observed on average at day 8 with the end-
point reached at day 20 (Fig 6E).
In vivo MR-IGRT of spontaneous pancreatic tumours in KPC mice
Localisation of spontaneous pancreatic tumours in the KPC model of PDAC can be achieved
by combining respiratory-gated bSSFP and CPMG MR imaging and the RT dose plan was pro-
duced as shown in Fig 7. Again, the tumour was inseparable using CBCT (Fig 7B) but well
resolved with MRI (Fig 7A) that facilitated target delineation and subsequent RT plan follow-
ing a prescription of 2 Gy (Fig 7C and 7D). Fig 8A illustrates adequate dose coverage of the
pancreatic tumour.
It currently remains unclear which is the optimal RT plan for irradiating intra-abdominal
tumours in the KPC mouse model of PDAC. For that purpose, the tumour and OARs were
contoured and the dose distribution to the tumour and OARs examined by plotting the dose-
volume histograms for four different plans (45˚ Arc, 0˚ beam, 30˚+60˚ arc and 2x120˚ arcs,
respectively). A dose-volume histogram example for a pancreatic tumour located on the upper
right side of the abdomen is shown in Fig 8C. All four plans achieved adequate and compara-
ble dose coverage of the pancreatic tumour. As expected, a single vertical static beam (0˚
beam) resulted in worse dose distribution to the unilateral (right) kidney and spleen but
slightly superior profile with better sparing of the contralateral (left) kidney compared to the
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other three plans. Interestingly, these three plans (especially 2x120˚ arcs) resulted in exposure
of larger volume of stomach and bowel to the lower RT dose range (0 Gy up to 5 Gy) compared
to 0˚ beam. No major differences were identified in the dose distribution to the liver among
the four tested plans.
Finally, it important to note that throughput can be maximised by using 2 support cradles
simultaneously with the current animal undergoing RT whilst the next animal to undergo RT
is being scanned under MRI. As a result, MRI-guided radiotherapy of 6 animals bearing
PDAC tumours could be completed within 2.5 h as the rate determining step is the duration of
the MRI procedure (approximately 25 minutes), rather than the entire procedure (approxi-
mately 40 minutes). As both the bSSFP and CPMG acquisitions were needed to accurately
Fig 5. In vivo MR-IGRT of the adrenal glands and histological validation by p-γH2AXSer139 staining. (A) respiratory-gated bSSFP MR image;
(B): RT planning CBCT image; (C) CBCT-MR image to guide the RT treatment delivery; (D) treatment plan for the adrenal; (E) The top row shows
fluorescent images of p-γH2AXSer139 that were acquired for 2 regions within the irradiated adrenal (column 1 and 2), the proximal kidney area to the
irradiated adrenal (column 3) and the non-irradiated contralateral adrenal (column 4). The sections were counterstained with DAPI to visualize
nucleus (middle row) and the merged image is shown in the bottom row. Representative images are shown.
https://doi.org/10.1371/journal.pone.0176693.g005
Fig 6. In vivo MR-IGRT of neuroblastoma xenografts. (A) respiratory-gated bSSFP MR image; (B): RT
planning CBCT image; (C) CBCT-MR image to guide the RT treatment delivery; (D) dose distribution for the
targeted treatment plan for a large tumour based on CBCT image to guide the RT treatment delivery: 2
radiotherapy fields with minimal overlap were used to cover the whole tumour whilst ensuring minimal
exposure of surrounding normal tissues. The tumour is indicated within a dashed line; (E) Tumour volume of
MRI-IGRT treated (5 Gy; n = 5) and non-irradiated control mice (n = 3). Values are expressed as
mean ± standard deviation.
https://doi.org/10.1371/journal.pone.0176693.g006
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identify the spontaneous PDAC tumours, throughput was slightly slower as compared to the
xenografts which could be operated with a turnaround time of approximately 15 minutes per
mouse.
Discussion
We describe here a MRI-guided radiotherapy method that takes advantage of the strengths of
each of its components: MRI for soft tissue contrast and target identification, CBCT for accu-
rate dose calculation and IGRT for accurate, collimated X-ray beam delivery. Each step of the
proposed MR-IGRT procedure was validated: from in vitro BANG gel tests to complex in vivo
targeting of abdominal organs, such as spontaneous pancreatic tumours in the KPC transgenic
mouse model.
A phantom study using BANG gel dosimeters was performed to validate the mechanical
accuracy of the MR-IGRT procedure. Such gels are radiologically soft-tissue equivalent and
are used routinely in the clinic to validate IGRT procedures [18]. Similarly, high resolution 3D
dose distribution measurements were obtained and indicated that a target, invisible for CBCT,
but clearly delineated using MRI, could be targeted with an error of approximately 2 pixels
(0.56 mm). This error results from multiple sources, including distortions arising from the
image formation processes, the digitisation of the target, errors consequent to the registration
process as well as the operator bias inherent to the use of trained operators prescribing the cen-
tre of rotation manually. Although the centre of the conical arc treatment did not perfectly
align with the centre of the target, the 0.6 mm targeting accuracy was comparable with a 3D
offset of 1 mm reported in a similar study using BLI as an imaging tool [32]. Therefore, auto-
mated image-guided isocentre definition has the potential to further increase the mechanical
accuracy of MR-IGRT.
However, phantom systems such as BANG gels do not reflect the in vivo situation for
which gastrointestinal, respiratory, cardiac and other motions are present during image forma-
tion, RT planning and RT delivery. To make the MR-IGRT work in vivo, subject immobilisa-
tion throughout the whole procedure is crucial as accurate registration of MRI-to-CT images
will depend on the magnitude of intra- and/or inter-scan displacements [10, 13]. To minimise
the effects of these an MR- and CBCT-compatible animal support cradle was developed. This
Fig 7. In vivo MR-IGRT of spontaneous pancreatic tumours in KPC mice. (A) respiratory-gated bSSFP MR image; (B) RT planning CBCT image; (C)
coronal and (D) sagittal view showing dose distribution (prescribed 2 Gy) based on CBCT-MR image to guide the RT treatment delivery. The colour heat map
indicates the RT doses.
https://doi.org/10.1371/journal.pone.0176693.g007
Efficient and robust MR-IGRT method for abdominal organs and tumours mouse
PLOS ONE | https://doi.org/10.1371/journal.pone.0176693 April 28, 2017 16 / 21
cradle features head fixation via a tooth bar assembly anaesthetic gas delivery, respiratory
monitoring and homeothermic temperature control. With appropriate operator care, the ani-
mal’s position within the cradle remains almost constant throughout the procedure. The latter
was formulated by Thorek et al. as a prerequisite for animal image registration [8, 13]. Instrin-
sic motions could be attributed solely to gastrointestinal contractions and general body droop
whilst extrinsic motions, due to the actual transport of the cradle between systems, were lim-
ited to 0.5 mm, approximately the same as the measured error in RT planning accuracy
derived from the validation tests using BANG gels. As a result, co-registration between MR
and CBCT images becomes straightforward and meaningful.
The first in vivo MR-IGRT test included targeting one adrenal gland with a size-matched
collimated beam whilst the other adrenal was spared. The adrenal glands are small organs
(approximately 1.5–3 mm in diameter) that are located on both sides of the body in the retro-
peritoneum, cranially to the kidney. They cannot be identified using CBCT but are readily
apparent in MR images. Any failure in any part of the MR-IGRT procedure would result in an
absent or partial distribution of the DNA double-strand break marker γH2AX foci, in the
MR-IGRT targeted adrenal glands. While the cell nuclei of the non-irradiated adrenal and the
kidney adjacent to the irradiated adrenal showed very few γH2AX foci, the foci were abundant
Fig 8. Determination of the optimal RT plan for intra-abdominal tumours in a mouse model of PDAC using a 10 mm diameter circular field. (A)
Planned dose profile for a pancreatic tumour determined at the isocentre, perpendicular to the angle of rotation (0˚) and perpendicular to the sagittal axis of
the mouse. (B) Illustration of MR image-based delineated tumour and organs at risk on the sagittal (left panel), coronal (middle panel) and 3-dimensionally,
as indicated. (C) Mean dose-volume histograms for a prescribed single dose of 8 Gy showing the dosimetric distribution of four radiotherapy plans (45˚ Arc,
0˚ beam, 30˚+60˚ arc and 2x 120˚ gantry arcs, respectively) to the intra-abdominal pancreatic tumour and the organs at risk in the KPC mouse model, as
indicated.
https://doi.org/10.1371/journal.pone.0176693.g008
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and homogenously distributed in the irradiated adrenal. This, together with the fact (1) that
the X-ray beam was collimated with dimensions matched to those of the adrenal gland and (2)
that the SARRP platform penumbra is sharp [6, 12], indicated that the MRI-guided procedure
was also accurate in an in vivo setting.
Further validation was performed by assessing the response-to-treatment of a neuroblas-
toma xenograft model. These tumours are invisible on CT images and show an endophytic
growth pattern, making them nearly undetectable when palpating the animal. These xenograft
tumours are hard to irradiate with conventional large field, single radiation beam X-Ray cabi-
nets, as the borders of the tumours are not discernible due to their non-solid structure. This
increases the risk of either not irradiating the whole tumour or exposing normal tissue from
surrounding organs to irradiation. Respiratory-gated bSSFP MRI could visualise these
tumours easily and quickly after which RT could be delivered. As proof-of-principle for X-ray
beam delivery, tumour growth was measured over time. As expected for the radiosensitive
neuroblastoma, tumour regression was observed almost immediately which confirms the accu-
racy of the MRI-guided radiotherapy method [30, 33].
Preclinical radiobiological research in PDAC has been limited by mouse models that do not
recapitulate the human biology and, more importantly, the significant technical challenges in
establishing a platform that enables precise irradiation of such tumours in mice. The in vivo
validation was concluded by using the KPC transgenic model of pancreatic cancer. As the pan-
creas is a diffuse organ in the mouse, these abdominal lesions are not readily identifiable by
CT, and their exact location cannot be predicted. This not only makes it difficult to identify
the lesions, but its abdominal location also poses challenges for imaging as any extra-cranial
organ cannot be easily immobilised. Both respiratory-gated bSSFP and CPMG MRI acquisi-
tions were used to identify the tumours in the abdomen. Moreover, the pancreatic tumours
could be separated from the normal pancreatic tissues without the need for contrast agents;
such agents can potentially influence the subsequent RT planning and delivery [6]. These
advantages make our proposed MR-IGRT method more robust compared to, for instance,
reversed-contrast imaging [8]. Once identified, the tumours could be easily targeted by the
MRI-guided radiotherapy method. Importantly, high throughput can be easily achieved when
two support cradles are used. If the MRI acquisitions fit within the 20 minutes needed for
radiotherapy planning and execution, then a turn-around time of 30 minutes per animal can
be achieved. This enables fractionated radiotherapy schedules for approximately 16 mice each
day. Finally, MR image-based target contouring and treatment planning facilitated evaluation
of dose distributions not only to the tumour but also to the OARs. We detected differences in
dose distribution among the four different plans. This can be of particular interest for RT toler-
ance investigations as small and large bowel toxicity constitutes a dose-limiting factor for RT
of PDAC [34] and will be investigated in future studies.
Further improvements to the entire procedure can be expected with the additional use of
functional or molecular imaging techniques that identify tumour with a higher sensitivity than
may be possible with anatomical MRI. However, the methods described are generally useful;
the cradles described can be used in multiple imaging systems from multiple vendors, and the
image registrations used in vivo were designed specifically to handle images acquired using
multiple different modalities. We anticipate the use of PET and/or SPECT imaging in conjunc-
tion with both MRI and RT in order to treat tumours according to their PET or SPECT tracer
uptake whilst ensuring minimum dose delivery to surrounding normal tissues as described by
MRI. Implementation of this multi-modal image-guided RT workflow is a straightforward
extension of the suite of techniques described in this report and will be investigated in further
studies.
Efficient and robust MR-IGRT method for abdominal organs and tumours mouse
PLOS ONE | https://doi.org/10.1371/journal.pone.0176693 April 28, 2017 18 / 21
Conclusion
The proposed MR-IGRT method presents a general solution to enabling robust, accurate and
efficient targeting of extracranial organs in the mouse and can operate with a sufficiently high
throughput to allow fractionated treatments to be given. Our preclinical MR-IGRT platform is
expected to provide important insight on the radiobiology research of clinically relevant
mouse models in the immediate future.
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S1 Fig. A flowchart representing the overall workflow and design of the reported study.
(TIF)
Acknowledgments
We would like to thank Dirk-Jan Kroon for the finite iterative closest point algorithm held at
MATLAB File Exchange. We also acknowledge expert technical assistance from the Institute
Mechanical and Electronics Workshops, animal facilities team and anyone else who contrib-
uted financially or in kind.
Author Contributions
Conceptualization: VK ALG JSB ACD NF KAV RJM BV MAH EF SCS.
Data curation: PDA.
Formal analysis: VK ALG JSB PK PDA JT LB ACD NF AA ZDC EF SCS.
Funding acquisition: KAV RJM BV MAH SCS.
Investigation: VK ALG JSB PK JT LB ACD AA ZDC EF SCS.
Methodology: VK ALG JSB ACD NF KAV RJM BV MAH EF SCS.
Project administration: VK RJM BV MAH EF SCS.
Resources: JSB SG PK PDA IDCT RGN KAV RJM BV MAH EF OJS SCS.
Supervision: VK ALG KAV RJM BV MAH EF SCS.
Validation: VK ALG JSB PK PDA JT LB ACD NF AA ZDC EF SCS.
Visualization: VK PDA JT ALG ZD LB ACD BV EF SCS.
Writing – original draft: VK ALG EF SCS.
Writing – review & editing: VK JSB SG PK PDA JT ALG ZD LB IDCT RGN ACD NF AA
KAV OJS RJM BV MAH EF SCS.
References
1. Tillner F, Thute P, Butof R, Krause M, Enghardt W. Pre-clinical research in small animals using radio-
therapy technology—a bidirectional translational approach. Z Med Phys. 2014; 24(4):335–51. https://
doi.org/10.1016/j.zemedi.2014.07.004 PMID: 25125191
2. Baumann BC, Benci JL, Santoiemma PP, Chandrasekaran S, Hollander AB, Kao GD, et al. An inte-
grated method for reproducible and accurate image-guided stereotactic cranial irradiation of brain
tumors using the small animal radiation research platform. Transl Oncol. 2012; 5(4):230–7. PubMed
Central PMCID: PMCPMC3431032. PMID: 22937174
Efficient and robust MR-IGRT method for abdominal organs and tumours mouse
PLOS ONE | https://doi.org/10.1371/journal.pone.0176693 April 28, 2017 19 / 21
3. Singh M, Murriel CL, Johnson L. Genetically engineered mouse models: closing the gap between pre-
clinical data and trial outcomes. Cancer Res. 2012; 72(11):2695–700. https://doi.org/10.1158/0008-
5472.CAN-11-2786 PMID: 22593194
4. Bibby MC. Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages.
Eur J Cancer. 2004; 40(6):852–7. https://doi.org/10.1016/j.ejca.2003.11.021 PMID: 15120041
5. Teicher BA. Tumor models for efficacy determination. Mol Cancer Ther. 2006; 5(10):2435–43. https://
doi.org/10.1158/1535-7163.MCT-06-0391 PMID: 17041086
6. Verhaegen F, Granton P, Tryggestad E. Small animal radiotherapy research platforms. Phys Med Biol.
2011; 56(12):R55–83. https://doi.org/10.1088/0031-9155/56/12/R01 PMID: 21617291
7. Siewerdsen JH, Moseley DJ, Bakhtiar B, Richard S, Jaffray DA. The influence of antiscatter grids on
soft-tissue detectability in cone-beam computed tomography with flat-panel detectors. Med Phys. 2004;
31(12):3506–20. https://doi.org/10.1118/1.1819789 PMID: 15651634
8. Thorek DL, Kramer RM, Chen Q, Jeong J, Lupu ME, Lee AM, et al. Reverse-Contrast Imaging and Tar-
geted Radiation Therapy of Advanced Pancreatic Cancer Models. Int J Radiat Oncol Biol Phys. 2015;
93(2):444–53. PubMed Central PMCID: PMCPMC4575601. https://doi.org/10.1016/j.ijrobp.2015.06.
001 PMID: 26238952
9. Bolcaen J, Descamps B, Deblaere K, Boterberg T, Hallaert G, Van den Broecke C, et al. MRI-guided
3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation
Research Platform (SARRP). J Neurooncol. 2014; 120(2):257–66. https://doi.org/10.1007/s11060-014-
1552-9 PMID: 25069566
10. Christian N, Lee JA, Bol A, De Bast M, Jordan B, Gregoire V. The limitation of PET imaging for biological
adaptive-IMRT assessed in animal models. Radiother Oncol. 2009; 91(1):101–6. https://doi.org/10.
1016/j.radonc.2008.11.014 PMID: 19097661
11. Gutierrez S, Descamps B, Vanhove C. MRI-Only Based Radiotherapy Treatment Planning for the Rat
Brain on a Small Animal Radiation Research Platform (SARRP). PLoS One. 2015; 10(12):e0143821.
PubMed Central PMCID: PMCPMC4669183. https://doi.org/10.1371/journal.pone.0143821 PMID:
26633302
12. Ford EC, Achanta P, Purger D, Armour M, Reyes J, Fong J, et al. Localized CT-guided irradiation inhib-
its neurogenesis in specific regions of the adult mouse brain. Radiat Res. 2011; 175(6):774–83.
PubMed Central PMCID: PMCPMC3142866. https://doi.org/10.1667/RR2214.1 PMID: 21449714
13. Zhang M, Huang M, Le C, Zanzonico PB, Claus F, Kolbert KS, et al. Accuracy and reproducibility of
tumor positioning during prolonged and multi-modality animal imaging studies. Phys Med Biol. 2008; 53
(20):5867–82. PubMed Central PMCID: PMCPMC2668861. https://doi.org/10.1088/0031-9155/53/20/
021 PMID: 18827321
14. Heinrich MP, Jenkinson M, Bhushan M, Matin T, Gleeson FV, Brady SM, et al. MIND: modality indepen-
dent neighbourhood descriptor for multi-modal deformable registration. Med Image Anal. 2012; 16
(7):1423–35. https://doi.org/10.1016/j.media.2012.05.008 PMID: 22722056
15. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, et al. Trp53R172H and
KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal ade-
nocarcinoma in mice. Cancer cell. 2005; 7(5):469–83. https://doi.org/10.1016/j.ccr.2005.04.023 PMID:
15894267
16. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and inva-
sive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003; 4(6):437–50.
PMID: 14706336
17. Kersemans V, Gilchrist S, Allen PD, Beech JS, Kinchesh P, Vojnovic B, et al. A resistive heating system
for homeothermic maintenance in small animals. Magn Reson Imaging. 2015; 33(6):847–51. PubMed
Central PMCID: PMCPMC4462590. https://doi.org/10.1016/j.mri.2015.03.011 PMID: 25863135
18. Baldock C, De Deene Y, Doran S, Ibbott G, Jirasek A, Lepage M, et al. Polymer gel dosimetry. Phys
Med Biol. 2010; 55(5):R1–63. PubMed Central PMCID: PMCPMC3031873. https://doi.org/10.1088/
0031-9155/55/5/R01 PMID: 20150687
19. Kersemans V, Thompson J, Cornelissen B, Woodcock M, Allen PD, Buls N, et al. Micro-CT for anatomic
referencing in PET and SPECT: radiation dose, biologic damage, and image quality. J Nucl Med. 2011;
52(11):1827–33. https://doi.org/10.2967/jnumed.111.089151 PMID: 21984798
20. Ma CM, Coffey CW, DeWerd LA, Liu C, Nath R, Seltzer SM, et al. AAPM protocol for 40–300 kV x-ray
beam dosimetry in radiotherapy and radiobiology. Med Phys. 2001; 28(6):868–93. https://doi.org/10.
1118/1.1374247 PMID: 11439485
21. Tryggestad E, Armour M, Iordachita I, Verhaegen F, Wong JW. A comprehensive system for dosimetric
commissioning and Monte Carlo validation for the small animal radiation research platform. Phys Med
Biol. 2009; 54(17):5341–57. PubMed Central PMCID: PMCPMC3365538. https://doi.org/10.1088/
0031-9155/54/17/017 PMID: 19687532
Efficient and robust MR-IGRT method for abdominal organs and tumours mouse
PLOS ONE | https://doi.org/10.1371/journal.pone.0176693 April 28, 2017 20 / 21
22. Jacques R, Wong J, Taylor R, McNutt T. Real-time dose computation: GPU-accelerated source model-
ing and superposition/convolution. Med Phys. 2011; 38(1):294–305. https://doi.org/10.1118/1.3483785
PMID: 21361198
23. Gyngell ML. The application of steady-state free precession in rapid 2DFT NMR imaging: FAST and
CE-FAST sequences. Magn Reson Imaging. 1988; 6(4):415–9. PMID: 3185135
24. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour
segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage.
2006; 31(3):1116–28. https://doi.org/10.1016/j.neuroimage.2006.01.015 PMID: 16545965
25. Oppelt A, Graumann R, Barfub H, Fischer H, Hartl W, Shajor W. FISP—A new fast MRI sequence. Elec-
tromedica. 1986; 54:15–8.
26. Scheffler K, Lehnhardt S. Principles and applications of balanced SSFP techniques. Eur Radiol. 2003;
13(11):2409–18. https://doi.org/10.1007/s00330-003-1957-x PMID: 12928954
27. Kinchesh Paul, Gilchrist Stuart, Gomes Ana L, Veerle K, Beech John, Allen Danny, et al., editors. Accel-
erated Imaging of the Mouse Body using k-space Segmentation, Cardio-Respiratory Synchronisation
and Short, Constant TR: Application to b-SSFP. ISMRM 24th Annual Meeting and Exhibition; 2016;
Singapore.
28. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Meth-
ods. 2012; 9(7):671–5. PMID: 22930834
29. Wang LM, Kevans D, Mulcahy H, O’Sullivan J, Fennelly D, Hyland J, et al. Tumor budding is a strong
and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol. 2009; 33(1):134–41.
https://doi.org/10.1097/PAS.0b013e318184cd55 PMID: 18971777
30. Corroyer-Dulmont A, Falzone N, Kersemans V, Thompson J, Hill M, Allen PD, et al. MRI-Guided Radio-
therapy of the SK-N-SH Neuroblastoma Xenograft Model Using a Small Animal Radiation Research
Platform. Br J Radiol. 2016:20160427. https://doi.org/10.1259/bjr.20160427 PMID: 27524406
31. Kinchesh P, Allen PD, Beech JS, Fokas E, Gilchrist S, Kersemans V, et al., editors. Dynamic Reacquisi-
tion for Respiratory Gated, Constant TR 2D Multi-Slice MRI. International Society for Magnetic Reso-
nance in Medicine 24th Annual Meeting & Exhibition; 2015; Toronto, ON, Canada.
32. Zhang B, Wang KK, Yu J, Eslami S, Iordachita I, Reyes J, et al. Bioluminescence Tomography-Guided
Radiation Therapy for Preclinical Research. Int J Radiat Oncol Biol Phys. 2016; 94(5):1144–53.
PubMed Central PMCID: PMCPMC4814325. https://doi.org/10.1016/j.ijrobp.2015.11.039 PMID:
26876954
33. Rutgers M, Buitenhuis CK, Hoefnagel CA, Voute PA, Smets LA. Targeting of meta-iodobenzylguanidine
to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
Int J Cancer. 2000; 87(3):412–22. PMID: 10897048
34. Ben-Josef E, Lawrence TS. Radiotherapy: the importance of local control in pancreatic cancer. Nature
reviews Clinical oncology. 2012; 9(1):9–10.
Efficient and robust MR-IGRT method for abdominal organs and tumours mouse
PLOS ONE | https://doi.org/10.1371/journal.pone.0176693 April 28, 2017 21 / 21
